152 related articles for article (PubMed ID: 38552306)
21. Mutational analysis of p27 (CDKN1B) and p18 (CDKN2C) in sporadic pancreatic endocrine tumors argues against tumor-suppressor function.
Lindberg D; Akerström G; Westin G
Neoplasia; 2007 Jul; 9(7):533-5. PubMed ID: 17710155
[TBL] [Abstract][Full Text] [Related]
22. The association between tuberous sclerosis and insulinoma.
Kim H; Kerr A; Morehouse H
AJNR Am J Neuroradiol; 1995 Aug; 16(7):1543-4. PubMed ID: 7484652
[TBL] [Abstract][Full Text] [Related]
23. The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth.
McKimpson WM; Yuan Z; Zheng M; Crabtree JS; Libutti SK; Kitsis RN
PLoS One; 2015; 10(12):e0145792. PubMed ID: 26709830
[TBL] [Abstract][Full Text] [Related]
24. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract][Full Text] [Related]
25. MEN1 gene mutations in 12 MEN1 families and their associated tumors.
Bartsch D; Kopp I; Bergenfelz A; Rieder H; Münch K; Jäger K; Deiss Y; Schudy A; Barth P; Arnold R; Rothmund M; Simon B
Eur J Endocrinol; 1998 Oct; 139(4):416-20. PubMed ID: 9820618
[TBL] [Abstract][Full Text] [Related]
26. Synchronous Insulinoma and Glucagonoma: A Review of the Literature.
Damaskos C; Dimitroulis D; Garmpi A; Antoniou EA; Kouraklis G; Psilopatis I; Mavri M; Diamantis E; Marinos G; Kyriakos G; Farmaki P; Patsouras A; Kontzoglou K; Garmpis N
In Vivo; 2023; 37(6):2402-2408. PubMed ID: 37905620
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
Marini F; Giusti F; Tonelli F; Brandi ML
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
[TBL] [Abstract][Full Text] [Related]
28. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue.
Mailman MD; Muscarella P; Schirmer WJ; Ellison EC; O'Dorisio TM; Prior TW
Clin Chem; 1999 Jan; 45(1):29-34. PubMed ID: 9895334
[TBL] [Abstract][Full Text] [Related]
29. Analysis of 55 patients with multiple endocrine neoplasia type 1-associated insulinoma from a single center in China.
Zhao Y; Yu J; Liu Y; Lyu L; Ping F; Xu L; Li W; Wang O; Xu Q; Wu W; Zhang H; Li Y
Orphanet J Rare Dis; 2022 Jun; 17(1):219. PubMed ID: 35698198
[TBL] [Abstract][Full Text] [Related]
30. Cystic glucagonoma with loss of heterozygosity on chromosome 11 in multiple endocrine neoplasia type 1.
Sarui H; Yoshimoto K; Okumura S; Kamura M; Takuno H; Ishizuka T; Takao H; Shimokawa K; Itakura M; Saji S; Yasuda K
Clin Endocrinol (Oxf); 1997 Apr; 46(4):511-6. PubMed ID: 9196616
[TBL] [Abstract][Full Text] [Related]
31. Whole-exome sequencing as a tool for searching for genetic background modifiers in MEN1 patients with neuroendocrine pancreatic tumours, including insulinomas.
Skalniak A; Trofimiuk-Müldner M; Jabrocka-Hybel A; Totoń-Żurańska J; Wołkow P; Hubalewska-Dydejczyk A
Endokrynol Pol; 2023; 74(1):31-46. PubMed ID: 36847722
[TBL] [Abstract][Full Text] [Related]
32. [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
Kianmanesh R; O'toole D; Sauvanet A; Ruszniewski P; Belghiti J
J Chir (Paris); 2005; 142(3):132-49. PubMed ID: 16142076
[TBL] [Abstract][Full Text] [Related]
33. Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumours.
Stridsberg M; Eriksson B; Lundqvist G; Skogseid B; Wilander E; Oberg K
Regul Pept; 1995 Jan; 55(2):119-31. PubMed ID: 7754100
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability.
Scacheri PC; Kennedy AL; Chin K; Miller MT; Hodgson JG; Gray JW; Marx SJ; Spiegel AM; Collins FS
Cancer Res; 2004 Oct; 64(19):7039-44. PubMed ID: 15466197
[TBL] [Abstract][Full Text] [Related]
35. DNA ploidy in pancreatic neuroendocrine tumors.
Alanen KA; Joensuu H; Klemi PJ; Marin S; Alavaikko M; Nevalainen TJ
Am J Clin Pathol; 1990 Jun; 93(6):784-8. PubMed ID: 2346135
[TBL] [Abstract][Full Text] [Related]
36. Chromosomal alterations in human pancreatic endocrine tumors.
Stumpf E; Aalto Y; Höög A; Kjellman M; Otonkoski T; Knuutila S; Andersson LC
Genes Chromosomes Cancer; 2000 Sep; 29(1):83-7. PubMed ID: 10918398
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic endocrine tumors.
Klöppel G; Heitz PU
Pathol Res Pract; 1988 Apr; 183(2):155-68. PubMed ID: 2898775
[TBL] [Abstract][Full Text] [Related]
38. A Novel Missense Mutation of the MEN1 Gene in a Patient with Multiple Endocrine Neoplasia Type 1 with Glucagonoma and Obesity.
Murakami T; Usui T; Nakajima A; Mochida Y; Saito S; Nambu T; Kato T; Matsuda Y; Yonemitsu S; Muro S; Oki S
Intern Med; 2015; 54(19):2475-81. PubMed ID: 26424307
[TBL] [Abstract][Full Text] [Related]
39. Asymptomatic insulinoma: a case report and autopsy series.
Kishi S; Sakamoto K; Mori M; Isogawa A; Shiba T
Diabetes Res Clin Pract; 2012 Dec; 98(3):445-51. PubMed ID: 23084041
[TBL] [Abstract][Full Text] [Related]
40. Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic Advances.
Guilmette JM; Nosé V
Adv Anat Pathol; 2019 Jan; 26(1):13-30. PubMed ID: 29912000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
